Topic: Bristol-Myers Squibb Company

AP News | 2010-03-09 22:58:07
2009 compensation for Bristol-Myers Squibb CEO Cornelius falls 22 percent amid recession

The chief executive of drugmaker Bristol-Myers Squibb Co., James Cornelius, received a 2009 compensation package valued by The Associated Press at $17 million, down 22 percent from 2008, due to the much lower value of his stock awards. The maker of blood thinner Plavix, schizophrenia treatment Abilify and ...

Continue reading... 
AP Features | 2010-03-05 14:53:05

Executives at Bristol-Myers Squibb Co. told analysts Thursday at a business briefing that the drugmaker has 60 potential drugs in development, seven in late-stage studies, and plenty of money for dealmaking. "Five potential new medicines could be introduced in the next three years," said Dr. Elliot Sigal, head of research and development. The company said it expects future revenue from ...

Continue reading... 
AP News | 2010-03-04 21:45:05
Key Bristol-Myers drugs in development target cancer types, transplants, heart disease

Some key experimental drugs in late-stage testing by biopharmaceutical company Bristol-Myers Squibb Co.: _ipilimumuab, for melanoma, the most dangerous type of skin cancer. Data from a late-stage study could be presented at a major cancer meeting in June; the company will soon seek regulatory approval for use in patients ...

Continue reading... 
AP News | 2010-03-04 15:50:29
Bristol-Myers expects profit of at least $1.95 a share in 2013, first full year without Plavix

Drugmaker Bristol-Myers Squibb Co. said Thursday it expects a profit of at least $1.95 per share in 2013, a crucial period because that's when U.S. generic competition will start wiping out sales of its top-selling medicine, the blood thinner Plavix ...

Continue reading... 
Mixed results from job-creation program

NBC 22 Springfield (WWLP) | 2010-03-14 16:24:21

Jobs program lost its way — and tax money

Boston Globe | 2010-03-14 03:19:18

Bristol-Myers, Sanofi update Plavix label warning

MarketWatch | 2010-03-12 13:35:10

Early Glance: Pharmaceuticals companies

CNBC | 2010-03-12 12:31:38

loading
loading
loading